1,402
Views
3
CrossRef citations to date
0
Altmetric
Cancer Biology

Prognostic value of baseline APACHE II score combined with uric acid concentration for short-term clinical outcomes in patients with sepsis

, , , &
Pages 416-425 | Received 05 Mar 2020, Accepted 06 Jul 2020, Published online: 31 Jul 2020

References

  • Akbar SR, Long DM, Hussain K, Alhajhusain A, Ahmed US, Iqbal HI, Ali AW, Leonard R, Dalton C. 2015. Hyperuricemia: An Early Marker for Severity of Illness in Sepsis. Int J Nephrol. 2015:301021. https://pubmed.ncbi.nlm.nih.gov/26294973/.
  • Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulmé R, et al. 2002. Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med. 28(2):108–121.
  • Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 29(7):1303–1310.
  • Angus DC, Wax RS. 2001. Epidemiology of sepsis: an update. Crit Care Med. 29(7):S109–S116.
  • Apostolova N, Garcia-Bou R, Hernandez-Mijares A, Herance R, Rocha M, Victor VM. 2011. Mitochondrial antioxidants alleviate oxidative and nitrosative stress in a cellular model of sepsis. Pharm Res. 28(11):2910–2919.
  • Brun-Buisson C, Meshaka P, Pinton P, Vallet B, EPISEPSIS Study Group. 2004. EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 30(4):580–588.
  • Chen Z, Shao Z, Mei S, Yan Z, Ding X, Billiar T, Li Q. 2018. Sepsis Upregulates CD14 Expression in a MyD88-Dependent and Trif-Independent Pathway. Shock. 49(1):82–89. https://pubmed.ncbi.nlm.nih.gov/28562479/.
  • Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, Chen MF. 2006. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care. 10(1):R36. https://pubmed.ncbi.nlm.nih.gov/16507162/.
  • Chuang T, Chang H, Chung K, Cheng H, Liu C, Liu Y, Huang H, Chou T, Chang B, Lee M, et al. 2014. High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis. Int J Infect Dis. 20:13–17.
  • Erdag G, Vitrinel A. 2004. Can urinary uric acid/creatinine ratio be used as an additional marker for neonatal asphyxia. Int Pediatr. 19(4):217–219.
  • Fabbri L, Rabe K. 2007. From COPD to chronic systemic inflammatory syndrome. Lancet. 370(9589):797–799.
  • Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. 2004. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 30(4):589–596.
  • Friedman AB. 2014. Economic incentives and use of the intensive care unit. JAMA. 311(22):2336–2337. https://pubmed.ncbi.nlm.nih.gov/24915272/.
  • Ganesh K, Sharma RN, Varghese J, Pillai MG. 2016. A profile of metabolic acidosis in patients with sepsis in an intensive care unit setting. Int J Crit Illn Inj Sci. 6(4):178–181.
  • Gooch RA, Kahn JM. 2014. ICU bed supply, utilization, and health care spending: an example of demand elasticity. JAMA. 311(6):567–568.
  • Gough M, Morgan M, Mack C, Darling D, Frasier L, Doolin K, Apostolakos M, Stewart J, Graves B, Arning E, et al. 2011. The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med. 39(6):1351–1358.
  • Hediger M, Johnson R, Miyazaki H, et al. 2005. Molecular physiology of urate transport. Physiology. 20:125–133.
  • Huang Y, Chen J, Zhong S, Yuan J. 2016. Role of APACHE II scoring system in the prediction of severity and outcome of acute intracerebral hemorrhage. Int J Neurosci. 126(11):1020–1024.
  • Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY, Lanaspa MA. 2013. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 62(10):3307–3315.
  • Jung WJ, Park BH, Chung KS, Kim SY, Kim EY, Jung JY, Kang YA, Kim YS, Kim SK, Chang J, et al. 2015. Glucagon levels, disease severity, and outcome in severe sepsis. Shock. 43(6):563–568.
  • Khandelwal N, Benkeser D, Coe NB, Engelberg RA, Teno JM, Curtis JR. 2016. Patterns of Cost for patients Dying in the intensive care unit and Implications for Cost Savings of Palliative care Interventions. J Palliat Med. 19(11):1171–1178.
  • Khandelwal N, Engelberg RA, Benkeser DC, Coe NB, Curtis JR. 2014. End-of-life expenditure in the ICU and perceived quality of dying. Chest. 146(6):1594–1603.
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: a severity of disease classification system. Crit Care Med. 13(10):818–829.
  • Kung C-T, Su C-M, Chen CT, Cheng H-H, Chang M-W, Hung C-W, Hung S-C, Ching W-N, Tsai N-W, Wang H-C. 2016. Circulating endothelial progenitor cells may predict outcomes in adult patients with severe sepsis in the emergency department. Clin Chim Acta. 455:1–6.
  • Lagu T, Rothberg M, Shieh M, Pekow P, Steingrub J, Lindenauer P. 2012. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 40(3):754–761.
  • Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF. 2010. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol. 138(2):206–209.
  • Lee HW, Choi SM, Lee J, Park YS, Lee CH, Yim JJ, Yoo CG, Kim YW, Han SK, Lee SM. 2019. Serum Uric Acid Level as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome. J Intensive Care Med. 34(5):404–410. https://pubmed.ncbi.nlm.nih.gov/28351229/.
  • Lee H, Lim C, Hong H, Ju J, Leong Y, Hwang J, Park H. 2015. Efficacy of the APACHE II score at ICU discharge in predicting post-ICU mortality and ICU readmission in critically ill surgical patients. Anaesth Intensive Care. 43(2):175–186.
  • Lewis G, Maxwell A. 2014. Risk factor control is key in diabetic nephropathy. Practitioner. 258(1768):13–17.
  • Li H-y, Li S-j, Yang N, Hu W-l. 2014. Evaluation of nosocomial infection risk using APACHE II scores in the neurological intensive care unit. J Clin Neurosci. 21(8):1409–1412.
  • Mantzarlis K, Tsolaki V, Zakynthinos E. 2017. Role of oxidative stress and Mitochondrial Dysfunction in sepsis and potential Therapies. Oxid Med Cell Longev. 2017:5985209. https://pubmed.ncbi.nlm.nih.gov/28904739/.
  • Martin Greg S, Mannino David M, Eaton S, Moss M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 348(16):1546–1554.
  • Nakhoda S, Zimrin A, Baer M, Law J. 2017. Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Transfus Apher Sci. 56(2):123–126.
  • Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. 2003. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med. 31(9):2332–2338.
  • Patel K, Makadia M, Patel V, et al. 2017. Urinary uric acid/creatinine ratio – A marker for Perinatal Asphyxia. J Clin Diagn Res. 11(1):SC8–SC10.
  • Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, Hollenberg NK, Fisher ND. 2004. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 66(4):1465–1470.
  • Ruggiero C, Cherubini A, Ble A, et al. 2006. Uric acid and inflammatory markers. Eur Heart J. 27(10):1174–1181.
  • Ruggiero C, Cherubini A, 3rd, Miller E, Maggio M, Najjar SS, Lauretani F, Bandinelli S, Senin U, Ferrucci L. 2007. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol. 100(1):115–121.
  • Shalaby MM, Sobeih AA, Abdulghany WE, Behiry EG, Ismail YM, Abd-El-Aziz MA. 2017. Mean platelet volume and serum uric acid in neonatal sepsis: A case-control study. Ann Med Surg (Lond. 20:97–102.
  • Sharaf El Din UAA, Salem MM, Abdulazim DO. 2017. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res. 8(5):537–548.
  • So A, Thorens B. 2010. Uric acid transport and disease. J Clin Invest. 120(6):1791–1799.
  • Vera S, Martínez R, Gormaz J, et al. 2015. Novel relationships between oxidative stress and angiogenesis-related factors in sepsis: New biomarkers and therapies. Ann Med. 47(4):289–300.
  • Victor VM, Espulgues JV, Hernandez-Mijares A, Rocha M. 2009. Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with mitochondria-targeted antioxidants. Infect Disord Drug Targets. 9(4):376–389.
  • Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. 2000. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med. 26(2):167–172.
  • Yan R, van Meurs M, Popa ER, Jongman RM, Zwiers PJ, Niemarkt AE, Kuiper T, Kamps JA, Heeringa P, Zijlstra JG, et al. 2017. Endothelial Interferon Regulatory Factor 1 Regulates Lipopolysaccharide-Induced VCAM-1 Expression Independent of NFkB. J Innate Immun. 9(6):546–560. https://pubmed.ncbi.nlm.nih.gov/28658674/.
  • Zahar J-R, Timsit J-F, Garrouste-Orgeas M, Français AV, Aurélien D-DA, Dubois Y, Souweine B, Haouache H, Goldgran-Toledano D, Allaouchiche B, et al. 2011. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med. 39(8):1886–1895.
  • Zharikov S, Krotova K, Hu H, et al. 2008. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 295(5):C1183–C1190.
  • Zheng G, Pan M, Jin W, et al. 2017. MicroRNA-135a is up-regulated and aggravates myocardial depression in sepsis via regulating p38 MAPK/NF-κB pathway. Int Immunopharmacol. 45:6–12.